Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Modulation of Cancer-Associated Fibrotic Stroma by An Integrin αvβ3 Targeting Protein for Pancreatic Cancer Treatment

Cellular and Molecular Gastroenterology and Hepatology(2020)10.1016/j.jcmgh.2020.08.004Source: DataRank Database

Modulation of Cancer-Associated Fibrotic Stroma by An Integrin αvβ3 Targeting Protein for Pancreatic Cancer Treatment is a research paper published in Cellular and Molecular Gastroenterology and Hepatology (2020). On theSindex it has a DataRank of 0. It has been cited 31 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access31 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 2.60)OA: goldTopics (67)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Malvika Sharma ORCID,Falguni Mishra ORCID,Alyssa M. Krasinskas ORCID,Yi Yuan ORCID,Jenny J. Yang ORCID

Live enrichment

PubMed:32810598 PMC:PMC7674520 OpenAlex:https://openalex.org/W3049390013

NCI NIH HHS

Grant: R01 CA118113

NCI NIH HHS

Grant: R01 CA175112

NCI NIH HHS

Grant: U44 CA217482

NCI NIH HHS

Grant: R42 CA217482

NCI NIH HHS

Grant: R41 CA217482

National Institutes of Health

Grant: 5R01CA175112-05

Development of anti-angiogenesis therapy targeting integrin

National Institutes of Health

Grant: 5U44CA217482-05

Development of a protein drug for pancreatic cancer treatment

National Institutes of Health

Grant: 2R01CA118113-06A1

P68 and Ca-calmodulin interaction in cell migration

National Cancer Institute

FWCI

2.60

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.jcmgh.2020.08.004

publisherhttps://doi.org/10.1016/j.jcmgh.2020.08.004

publisherhttps://api.elsevier.com/content/article/PII:S2352345X20301284?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352345X20301284?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32810598

Fields of Study

Cell Adhesion Molecules ResearchAngiogenesis and VEGF in CancerProteoglycans and glycosaminoglycans research0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsAntineoplastic AgentsApoptosisCarcinoma, Pancreatic DuctalCell Line, TumorDisease Models, AnimalHumansIntegrin alphaVbeta3MiceMice, TransgenicPancreatic NeoplasmsPancreatic Stellate CellsPrimary Cell CultureXenograft Model Antitumor Assays

MeSH Terms

AnimalsAntineoplastic AgentsDisease Models, AnimalHumansMice, TransgenicPancreatic NeoplasmsApoptosisCarcinoma, Pancreatic DuctalXenograft Model Antitumor AssaysIntegrin alphaVbeta3Cell Line, TumorMicePancreatic Stellate CellsPrimary Cell Culture

Keywords

StromaPancreatic cancerIntegrinCancer researchCancerMedicinePathologyInternal medicineOncologyImmunohistochemistryReceptorCollagengemcitabinePancreatic Stellate CellsIntegrin Α(v)β(3)Pancreatic Cancer TreatmentPrimary Cell CultureAntineoplastic AgentsApoptosisMice, TransgenicRC799-869Diseases of the digestive system. GastroenterologyIntegrin alphaVbeta3Xenograft Model Antitumor AssaysPancreatic NeoplasmsDisease Models, AnimalMiceCell Line, TumorIntegrin αvβ3AnimalsHumansOriginal ResearchCarcinoma, Pancreatic Ductal

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being